In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Cardiovascular Surgery Nucleus Meeting Report

Chamonix, 20-21 January 2012

The last meeting of the Working Group on Cardiovascular Surgery was held in Chamonix on January 20-21st, 2012.

A first consideration done was that, according to recent meetings which focused on the ESC/EACTS 2010 myocardial revascularization guidelines, the implementation rate of the guidelines in Europe is still rather low. Therefore national societies should increase their interaction with ESC in order to assess on an annual basis the achievements realized in terms of guidelines implementations. In addition proper patient consent should be encouraged and appropriate revascularization modalities should be discussed by the heart team. From that point of view the WG feels that it is extremely important to avoid confusion and misconception regarding which CAD patients should be discussed by the heart team. Therefore two algorithms were prepared during the meeting showing the pathway to follow in choosing the most appropriate intervention in CAD patients and when the patient needs to be discussed by the heart team. Those charts will be proposed for inclusion into the new ESC guidelines on stable angina.

The Survey promoted by the WG on the implementation of the myocardial revascularization guidelines and MDT approach in cardiovascular disease was discussed and is now ready to be published on the ESC web site.

In addition the WG position paper on “Management of anti-thrombotic therapy in patients with coronary artery disease undergoing CABG” was presented. The manuscript was carefully reviewed by all the nucleus members and will be further reviewed by the ESC antithrombotic therapy experts before the final submission.

In terms of educational purposes, the Nucleus members identified the following as two important areas where training is more needed and should be encouraged:
- mitral valve repair
- more use of arterial grafts for myocardial revascularization

Dedicated grants will be found mainly from industries to offer training periods in those fields to trainees.

Finally a decision was made about scheduling the next WG meeting in August 2012 during the ESC Congress.